Dr. Mohammad  Shayestehpour
My Social Links

Dr. Mohammad Shayestehpour

Assistant Professor
Kashan University of Medical Sciences, Kashan, Iran

Highest Degree
Ph.D. in Molecular and Medical Virology from Tehran University of Medical Sciences, Tehran, Iran

Share this Profile

Area of Interest:

Biomedical Sciences
Health Sciences
Oncogenic Viruses
Molecular Virology

Research Publications in Numbers


Selected Publications

  1. Vahedian-Ardakani, H.A., M. Moghimi, M. Shayestehpour, M. Doosti and F. Alimohammadi, 2018. Survival rate of patients with bladder cancer in Yazd, Central province of Iran. Int. J. Cancer Manage., Vol. 11, No. 5. 10.5812/ijcm.61436.
    CrossRef  |  Direct Link  |  
  2. Shayestehpour, M., 2018. Oncolytic viruses: Can be applicable tools for cancer therapy? J. Virus Adaptation Treat., 1: 1-2.
    Direct Link  |  
  3. Yazdani, S., V. Salimi, M.R. Eshraghian, M. Shayestehpour and A. Pourtalebi-Firoozabadi et al., 2017. No genetic association between A118G polymorphism of μ-opioid receptor gene and schizophrenia and bipolar disorders. Indian J. Psychiatry, 59: 483-486.
    CrossRef  |  PubMed  |  Direct Link  |  
  4. Shayestehpour, M., S. Moghim, V. Salimi, S. Jalilvand, J. Yavarian, B. Romani and T. Mokhtari-Azad, 2017. Targeting human breast cancer cells by an oncolytic adenovirus using microRNA-targeting strategy. Virus Res., 240: 207-214.
    CrossRef  |  Direct Link  |  
  5. Jamil, R.K., M. Shayestehour, Z.A. Sadigh, M. Taqavian and M.K. Shahkarami et al., 2017. The effect of various stabilizers on preserving immunogenicity of lyophilized mumps vaccines. J. Res. Health Sci., Vol. 17, No. 4. .
    Direct Link  |  
  6. Bagheri, S., P. Rahimi, R. Vahabpour, F. Motevalli, M. Shayestehpour, M.R. Amiran and S. Yazdani, 2017. Truncated JFH1 E2 protein: Is it reliable to be used in diagnostic ELISA test and as a protein-based vaccine candidate? Protein Pept. Lett., 24: 1179-1184.
    CrossRef  |  Direct Link  |  
  7. Ardakani, H.A.V., M. Moghimi, M. Shayestehpour, M. Doosti and S.B. Sharifabadi, 2017. Survival of patients with thyroid cancer in Yazd, Iran. Asian Pac. J. Cancer Prev., 18: 2293-2297.
    CrossRef  |  PubMed  |  Direct Link  |  
  8. Ardakani, H.A.V., M. Moghimi, M. Shayestehpour, M. Doosti and F.S. Shahrbabaki, 2017. Survival outcome in men with prostate cancer in Yazd province, Central Iran, from 2001 to 2012. Asian Pac. J. Cancer Biol., 2: 23-26.
  9. Shayestehpour, M., S. Moghim, V. Salimi, S. Jalilvand and J. Yavarian et al., 2016. Selective replication of miR-145-regulated oncolytic adenovirus in MCF-7 breast cancer cells. Future Virol., 11: 671-680.
    CrossRef  |  Direct Link  |  
  10. Doosti, M., M. Bakhshesh, S.T. Zahir, M. Shayestehpour and M. Karimi-Zarchi, 2016. Lack of evidence for a relationship between high risk human papillomaviruses and breast cancer in Iranian patients. Asian Pac. J. Cancer Prev., 17: 4357-4361.
    PubMed  |  Direct Link  |  
  11. Ansari, N., M. Doosti, A. Ahmadi, E. Kakavandi, S. Yazdani and M. Shayestehpour, 2016. Distribution of hepatitis C virus genotypes in Yazd, Central province of Iran: Increasing the mixed genotypes. Iran. J. Virol., 10: 19-24.
    Direct Link  |  
  12. Vasmehjani, A.A., D. Javeshghani, R. Baharlou, M. Shayestehpour, S.D. Mousavinasab, N. Joharinia and S.E. Enderami, 2015. Hepatitis A infection in patients with chronic viral liver disease: A cross-sectional study in Jahrom, Iran. Epidemiol. Infect., 143: 534-539.
    CrossRef  |  Direct Link  |  
  13. Shahkarami, M.K., M. Shayestehpour, A. Sancholi, M. Taqavian, R.K. Jamil, F. Esna-Ashari and R. Shahbazi, 2015. Application of real-time PCR method for evaluation of measles vaccine heat stability. J. Paramed. Sci., 6: 26-30.
    Direct Link  |  
  14. Rahimi, P., R. Solati, M. Shokri, R. Vahabpour and F. Mahmoudizad et al., 2015. Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate. Vaccine Res., 2: 74-80.
    Direct Link  |  
  15. Moghimi, M., M. Doosti, H.A. Vahedian-Ardakani, A. Talebi and M. Akhavan-Ghalibaf et al., 2015. Serological study on cytomegalovirus and Toxoplasma gondii in thalassemia major patients of Yazd, Iran. Iran. J. Pediatr. Hematol. Oncol., 5: 149-154.
    PubMed  |  
  16. Shahsavandi, S., A. Ahmadi-Vasmehjani, M. Shayestehpour, K. Sadeghi, M.M. Ebrahimi and H. Fazel, 2014. Sequencing and phylogenetic analysis of NS gene of two isolates of H9N2 influenza virus and the growth characteristics of the virus on A549 cells. J. Isfahan Med. School, 32: 432-441.
  17. Hafez, A.A., R. Baharlou, S.D.M. Nasab, A.A. Vasmehjani, M. Shayestehpour, N. Joharinia and N.A. Ahmadi, 2014. Molecular epidemiology of different hepatitis C genotypes in serum and peripheral blood mononuclear cells in Jahrom City of Iran. Hepatitis Monthly, Vol. 14, No. 5. 10.5812/hepatmon.16391.
    CrossRef  |  Direct Link  |  
  18. Doosti, M., M. Bakhshesh, S. Taghipour-Zahir, A. Hatami, M. Shayestehpour and M. Moghimi, 2014. The relationship of low-risk (6, 11) and high-risk types (16, 18) of Papilloma virus and human breast cancer in women. J. Isfahan Med. School, 32: 368-377.
  19. Baghbanian, M., A. Karimi-Bondarabadi, M. Doosti, M. Shayestehpour and H. Salmanroghani et al., 2014. Diagnostic and epidemiologic features of hepatitis C among hemodialysis patients living in Yazd province of Iran. Iran. J. Virol., 8: 25-30.
    Direct Link  |  
  20. Ahmadi-Vasmehjani, A., S.D. Mousavi-Nasab, R. Baharlou, F. Jeirani and M. Shayestehpour et al., 2013. Diagnosis of foot-and-mouth disease virus by real time reverse transcription polymerase chain reaction assay in Iran. Iran. J. Virol., 7: 21-29.
    Direct Link  |  
  21. Shayestehpour, M., A. Shafyi, M. Taqavian, F. Esna-Ashari and A. Mohammadi et al., 2012. A study of the thermal stability of measles vaccine produced by AIK-C strain. Arak Med. Univ. J., 15: 26-33.
  22. Hosseini, S.M., B. Tabaraei, S. Hadadian, F. Yavari and R. KamaliJamil et al., 2011. Increased the specificity and sensitivity of monospecific antibody against Host Cell Protein (HCP) in quality control of hepatitis B recombinant vaccine. J. Paramed. Sci., 2: 24-29.
    Direct Link  |